Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER2). A double-blind, placebo-controlled study of extended-release Niacin on Atherosclerosis progression in secondary prevention patients treated with statins. - Taylor,A.J.; Sullenberger,L.E.; Lee,H.J.; Lee,J.K.; Grace,K.A. (Circulation, 2004)